作者单位:
Department of Neurology, University Hospital "12 de Octubre", Madrid, Spain.
[1]
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
[2]
Department of Medicine, Complutense University, Madrid, Spain.
[3]
Faculty of Experimental Sciences, Francisco de Vitoria University, Pozuelo de Alarcón, Madrid, Spain.
[4]
Brain Damage Unit, Hospital Beata Maria Ana, Madrid, Spain.
[5]
Department of Neurology, Yale School of Medicine, Yale University, New Haven, CT, USA.
[6]
Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, Connecticut.
[7]
Center for Neuroepidemiology and Clinical Neurological Research, Yale School of Medicine, Yale University, New Haven, Connecticut.
[8]
Department of Neurology, HM CINAC, University Hospital HM Puerta del Sur, Móstoles, Spain.
[9]
Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts.
[10]
Pacific Parkinson's Research Centre and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
[11]
Faculty of Biosanitary Sciences, ISLA, Computer Science Faculty, A Coruña University, A Coruña, Spain.
[12]
DOI
10.1002/acn3.50916
PMID
31588694
发布时间
2020-12-13